The results demonstrated that TYTW containing bioactive compounds, including agrimoniin, baicalin, corosolic acid, and luteolin, might mitigate gastric cancer via effects on the PI3K/AKT, gastric cancer, and MAPK signaling pathways and related biological processes. The gene discussed is AKT1; the disease is gastric cancer.